The osmotic resistance of the erythrocytes can be used as a sensitive marker for the detection of the early stages of hyperglycemia (prediabetes). This set of clinical trials will make it possible to identify diseases that make up the triad at an early stage. Early detection of disorders and continued research in this direction will help in the development of a diagnostic scheme for the prevention of such patients. Based on our data, research into anti-oxidation drugs is very important. With the help of the array of studies described in the article and antioxidant treatment, the likelihood of successful treatment will increase.
Keyphrases
- early stage
- clinical trial
- end stage renal disease
- chronic kidney disease
- ejection fraction
- newly diagnosed
- oxidative stress
- prognostic factors
- high resolution
- hydrogen peroxide
- randomized controlled trial
- electronic health record
- high throughput
- patient reported outcomes
- radiation therapy
- loop mediated isothermal amplification
- combination therapy
- diabetic rats
- anti inflammatory
- visible light
- case control
- drug induced